Tirzepatide access
Yucca Health vs Maximus: Which One Offers Tirzepatide? (2026)
Compare Yucca Health and Maximus on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.5 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Yucca Health and Maximus both prescribe GLP-1 medication online, take payment directly from the patient and ship to the door. That is where the overlap stops.
Only one of these two gives you a route to tirzepatide. Yucca Health offers it at $258/mo; Maximus publishes a semaglutide program only, which caps where treatment can go if semaglutide underdelivers.
What follows is a like-for-like read of both programs: entry pricing, maintenance pricing, formulary, support model and the terms attached to each. Gaps in a provider's disclosure are reported as gaps, because they are part of what you are buying.
The short answer
- Lowest 12-month cost
- Maximus — $1,596 against $1,752 at Yucca Health, on each provider's own best published pricing.
- Most predictable bill
- Yucca Health — Price locked for the life of the plan, so titration does not change what you are charged.
- Tirzepatide access
- Yucca Health — Tirzepatide at $258/mo; the other side publishes semaglutide only.
- Most support included
- Maximus — Prescriptions approved by licensed doctors, filled through U.S. pharmacies.
Side-by-side comparison
Every figure below is the provider's own published number. The blank spaces are theirs, not ours.
| Yucca Health | Maximus | |
|---|---|---|
| Advertised price | Semaglutide $146/mo, tirzepatide $258/mo | $132.99/mo |
| Rate after promotions | $146/mo | $133/mo |
| Pricing structure | Price locked for the life of the plan | Flat rate at every dose |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| Tirzepatide | $258/mo | Not published |
| State coverage | All 50 states | Not published |
| How fast you start | Approval within 24 hours | Telemedicine intake, no clinic visits |
| Membership fee | None | None |
| Payment options | Klarna, Afterpay and Affirm | Card only, no financing published |
| Patient reviews | 36,958 | 2,896 |
| eRxDoctor score | 9.5/10 | 7.0/10 |
What you will have spent by month twelve
Trial data runs to 68 and 72 weeks; the pricing people compare runs to 30 days. Here is what each one costs across a realistic course of treatment, on published pricing.
| Yucca Health | Maximus | |
|---|---|---|
| First month | $146 | $133 |
| Months 2 onward | $146/mo | $133/mo |
| 6-month total | $876 | $798 |
| 12-month total | $1,752 | $1,596 |
| Best published plan | 6-month semaglutide plan at $875 — $1,752/yr | No multi-month discount published |
Over a year that is a $156 difference, in Maximus's favor. Whether it is the right call depends on whether Yucca Health gives you $13 a month of something you will use.
Semaglutide, tirzepatide, and having somewhere to go next
Semaglutide is a GLP-1 receptor agonist. Tirzepatide adds GIP activity, and in head-to-head trial data it has produced larger average weight reductions. That does not make it the right first choice for everyone — it is typically more expensive and the side-effect profile is its own conversation — but it is the usual next step when semaglutide underdelivers.
Yucca Health publishes both, with tirzepatide at $258/mo. Maximus publishes compounded semaglutide, so switching molecules would mean switching provider, repeating an intake and losing whatever pricing you had locked in.
The question to ask yourself is not which molecule you want now, but how much friction a change would create later.
Yucca Health: what you are buying
Yucca Health (TryYucca) review 2026: personalized compounded semaglutide from $146/month and tirzepatide from $258/month. Fast 24-hr approval, UPS 2-Day Air, Klarna/Affirm/Afterpay accepted. Against Maximus, that puts it in the position of the more expensive option.
From signup to first shipment: approval within 24 hours, then UPS 2-Day Air from a licensed U.S. compounding pharmacy. Billing follows a price locked for the life of the plan structure.
Support: personalized treatment plans from board-certified providers. The medications on offer are compounded semaglutide and compounded tirzepatide.
Yucca Health pros
- Compounded tirzepatide from $258/month, dual GIP/GLP-1 mechanism for higher average weight loss
- Compounded semaglutide from $146/month, one of the lowest prices from a legitimate GLP-1 telehealth provider
- Three Buy Now Pay Later options: Klarna, Afterpay, and Affirm
- 6-month semaglutide plan at $875 locks in the best per-month rate
Yucca Health cons
- No branded FDA-approved medications (Ozempic, Wegovy, Zepbound)
- Does not accept health insurance
- No weight loss warranty or outcome guarantee
Set beside Maximus, the thing to weigh: no branded medication, no insurance billing and no outcome guarantee.
Maximus in detail
$132.99 per Month What it is really selling here is a low flat rate with a simple direct-pay structure and nothing bolted on.
You start with telemedicine intake, no clinic visits; medication arrives via home delivery. The price behaves as flat rate at every dose.
Ongoing care is prescriptions approved by licensed doctors, filled through U.S. pharmacies, and the medication list runs to compounded semaglutide.
Maximus pros
- Simple, straightforward direct-pay model
- Low flat rate at $132.99/month
- Convenient telemedicine access with no clinic visits
- Prescriptions approved by licensed doctors
Maximus cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Smallest patient base on this list, limited public reviews and track record
- No published outcome or weight loss guarantee
Where it gives ground to Yucca Health: the smallest patient base here, with limited published detail on tirzepatide.
Who should choose Yucca Health, and who should choose Maximus
Choose Yucca Health if:
- you are willing to commit for a term in exchange for a lower effective rate (6-month semaglutide plan at $875)
- you are in a state where GLP-1 telehealth coverage is patchy
- the level of clinical contact suits you: personalized treatment plans from board-certified providers
- the feature you would actually use: a price lock at $146 plus three buy-now-pay-later options, which is unusual at the bottom of the market
Choose Maximus if:
- delivery works the way you want it to: home delivery
- you want to start on their timeline: telemedicine intake, no clinic visits
- the level of clinical contact suits you: prescriptions approved by licensed doctors, filled through U.S. pharmacies
- the feature you would actually use: a low flat rate with a simple direct-pay structure and nothing bolted on
What each one gives up
On price. The monthly gap is 10% in Maximus's favor. Whether that is a saving or a false economy turns on one thing: the smallest patient base here, with limited published detail on tirzepatide.
On commitment. Yucca Health rewards a longer commitment (6-month semaglutide plan at $875), which lowers the effective rate but ties up money before you know how you respond to the medication. Financing is available through Yucca Health (Klarna, Afterpay and Affirm).
On predictability. Price locked for the life of the plan at Yucca Health, against flat rate at every dose at Maximus. The more predictable structure is worth a premium to anyone who has been surprised by a telehealth invoice before.
On access. Yucca Health advertises approval within 24 hours and UPS 2-Day Air from a licensed U.S. compounding pharmacy; Maximus advertises telemedicine intake, no clinic visits and home delivery. Coverage differs too — all 50 states against not published — which decides the question before price does if you are in a restricted state.
Evidence and regulatory status
The efficacy data people cite when comparing these platforms is not platform data. It comes from trials of the underlying medication, and it applies to both.
NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.
SURMOUNT-4 found that continuing tirzepatide maintained and extended weight reduction, while withdrawing it led to substantial regain, per JAMA, SURMOUNT-4.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
Yucca Health vs Maximus: common questions
Which is cheaper to start, Yucca Health or Maximus?
Maximus, at $133 against $146. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which costs less over a year, Yucca Health or Maximus?
Maximus, at roughly $1,596 for twelve months against $1,752 at Yucca Health, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Is Maximus cheaper than Yucca Health?
Yes, on the ongoing rate. Maximus runs $133/mo once promotional pricing ends, against $146/mo at Yucca Health — a difference of 10%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
How fast can I start with Yucca Health compared with Maximus?
Yucca Health advertises approval within 24 hours, with UPS 2-Day Air from a licensed U.S. compounding pharmacy. Maximus advertises telemedicine intake, no clinic visits, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Does Yucca Health or Maximus offer tirzepatide?
Yucca Health does, at $258/mo. Maximus publishes compounded semaglutide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
Do Yucca Health and Maximus prescribe the same medication?
Both dispense compounded GLP-1 preparations. Yucca Health lists compounded semaglutide and compounded tirzepatide and Maximus lists compounded semaglutide, so the molecules overlap even where the formulary does not match exactly.
Do Yucca Health or Maximus take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
The verdict
Strictly on cost, Maximus takes it — $1,596 to $1,752 over twelve months.
Yucca Health earns the difference in one situation: when a price lock at $146 plus three buy-now-pay-later options, which is unusual at the bottom of the market is something you will genuinely use. If you cannot say that out loud, take the cheaper program.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- Yucca Health vs altRxBudget vs premium
- Yucca Health vs Enhance MDBudget vs premium
- Elevate Health vs MaximusTirzepatide access
- Mochi Health vs MaximusLocked price vs escalating price
- Novi vs Mochi HealthTirzepatide access
- IVIM Health vs Elevate HealthTirzepatide access
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Yucca Health or Maximus, and does not sell treatment. Read our ranking methodology.